Maintains mitochondrial function and reduces oxidative stress
So, it may be of little surprise that GLP-1 agonists could be used to address other metabolic disorders, apart from diabetes and obesity, like cardiovascular diseases
1 To date, multiple mechanisms of tissue damage have been implicated in SLE, including oxidative stress and free radicals, fibrosis, complement-mediated pathways, and a panoply of enzymatic cascades including matrix metalloproteinases, the renin-angiotensin system, plasmin, and kallikreins
Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages
The test analyzes four key variants affecting GLP-1 responsiveness, appetite regulation (MC4R), and fat storage (FTO)